In clinical studies, LIXI has shown the benefits of weight loss, which is well tolerated by patients and can meet the needs of overweight patients for weight control
Approximately five of the 19 peptides are expected to remain on the Category 2 list due to more significant safety concerns or weaker human evidence
[10] [1] Patients should seek medical advice if they experience symptoms such as a lump in the neck, persistent hoarseness, or difficulty swallowing
While DTC models may improve access and shift employer prescription costs, theres no evidence that they will solve the obesity burden or reduce total healthcare costs long-term
The body burns more energy at rest, particularly from fat stores
SGLT2 inhibitors, metformin, and structured nutrition and exercise programs do not carry the same monitoring burden in a coinfection-history liver, and they may be a reasonable first step